Permeasis Therapeutics (“Permeasis”), a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform announced the publication of ...

The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the ...

Few areas of medicine generate as much fascination, hope, hype, and confusion as genetics. Just over two decades ago, ...

ASCO 2026 marked an important transition in oncology. Rather than showcasing isolated advances, the meeting demonstrated how ...

Dr. Priya Hays discusses the mechanisms of treatment resistance in cancer, highlighting their significance for developing ...

The International Union for Conservation of Nature has published a new assessment that revises the gopher tortoise’s status from “vulnerable” to “critically endangered” on the IUCN Red List of ...

Bacteria that live peacefully in the human gut can aim molecular syringes at intestinal cells and fire proteins directly into ...

South Africa’s elephant strategy rightly celebrates heritage, culture and coexistence. But it’s proposals for adaptive management and flexibility could threaten what protection elephants actually ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared ...

United Therapeutics Corporation announced today it has acquired Thymmune Therapeutics, Inc. (Thymmune), a privately held, preclinical stage biotechnology company developing scalable, regenerative ...